Antifungal activity of novel catecholamine ruthenium(III) complexes

被引:15
作者
de Lima, RG
Lever, ABP
Ito, IY
da Silva, RS
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14040903 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Pret, Dept Quim, BR-14040901 Sao Paulo, Brazil
[3] York Univ, Dept Chem, N York, ON M3J 1P3, Canada
基金
巴西圣保罗研究基金会;
关键词
D O I
10.1023/A:1022967403627
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
New catecholamine ruthenium(III) complexes with potentially interesting biological activity are described. The complexes were prepared by reacting catecholamine with [RuCl(NH3)(5)]Cl-2. The newly prepared species were formulated as [Ru-III(NH3)(4)(catecholamine-R)](n+) where catecholamine- R = noradrenaline, dopamine and isoproterenol, and were characterized by elemental analysis, e.p.r., electronic absorption and f.t.-i.r. They were moderately stable in water at room temperature for at least 1 week. In vitro tests of antifungal activity showed the ruthenium catecholamine complexes had strong inhibitory action against the pathogenic yeast Candida albicans, Candida glabrata and Candida tropicalis. Free catecholamine does not show any antifungal activity.
引用
收藏
页码:272 / 275
页数:4
相关论文
共 42 条
[31]   Catecholamine complexes of ruthenium-edta and their redox chemistry [J].
Rein, FN ;
Rocha, RC ;
Toma, HE .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 85 (2-3) :155-166
[32]   Changing the electrochemical behavior of catechols by means of their conversion into the corresponding ruthenium(III)-dioxolene complexes [J].
Rein, FN ;
Rocha, RC ;
Toma, HE .
JOURNAL OF ELECTROANALYTICAL CHEMISTRY, 2000, 494 (01) :21-29
[33]   Interaction of antimalarial drug quinacrine with nucleic acids of variable sequence studied by spectroscopic methods [J].
Rivas, L ;
Murza, A ;
Sánchez-Cortés, S ;
García-Ramos, JV .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2000, 18 (03) :371-383
[34]   Tolcapone increases plasma catecholamine levels in patients with Parkinson's disease [J].
Rojo, A ;
Fontán, A ;
Mena, MA ;
Herranz, A ;
Casado, S ;
de Yébenes, JG .
PARKINSONISM & RELATED DISORDERS, 2001, 7 (02) :93-96
[35]   Metal complexes in medicine: Design and mechanism of action [J].
Sadler, PJ ;
Guo, ZJ .
PURE AND APPLIED CHEMISTRY, 1998, 70 (04) :863-871
[36]  
SADLER PJ, 1991, ADV INORG CHEM, V36, P1
[37]   Syntheses, antitumor activity, and molecular mechanics studies of cis-PtCl2(pzH)2 (pzH = pyrazole) and related complexes.: Crystal structure of a novel Magnus-type double-salt [pt(pzH)4][PtCl4][cis-PtCl2(pzH)2]2 involving two perpendicularly aligned 1D chains [J].
Sakai, K ;
Tomita, Y ;
Ue, T ;
Goshima, K ;
Ohminato, M ;
Tsubomura, T ;
Matsumoto, K ;
Ohmura, K ;
Kawakami, K .
INORGANICA CHIMICA ACTA, 2000, 297 (1-2) :64-71
[38]   Coordination compounds in medicinal chemistry [J].
Schwietert, CW ;
McCue, JP .
COORDINATION CHEMISTRY REVIEWS, 1999, 184 :67-89
[39]   The neurochemical basis of learning and neurocomputation: the redox theory [J].
Smythies, J .
BEHAVIOURAL BRAIN RESEARCH, 1999, 99 (01) :1-6
[40]  
Stochel G, 1998, COORDIN CHEM REV, V171, P203